Article
Activating Fgfr3 Y367C mutation causes hearing loss and inner ear defect in a mouse model of chondrodysplasia.
Biochimica et biophysica acta - 1 Feb 2009
Pannier Stéphanie, Couloigner Vincent, Messaddeq Nadia, Elmaleh-Bergès Monique, Munnich Arnold, Romand Raymond, Legeai-Mallet Laurence
Abstract excerpt
Fibroblast growth factor receptor 3 (FGFR3) is a key regulator of skeletal development and activating mutations in FGFR3 cause skeletal dysplasias, including hypochondroplasia, achondroplasia and thanatophoric dysplasia. The introduction of the Y367C mutation corresponding to the human Y373C thanatophoric dysplasia type I (TDI) mutation into the mouse genome, resulted in dwarfism with a skeletal phenotype...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
